Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review
Author:
Funder
Cancer Research UK
Institute of Cancer Research
National Institute for Health and Care Research
Publisher
Elsevier BV
Subject
General Medicine
Reference15 articles.
1. Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022;Araujo;Ann Oncol,2022
2. Moving beyond 3+3: the future of clinical trial design;Kurzrock;Am Soc Clin Oncol Educ B,2021
3. Appraising iniparib, the PARP inhibitor that never was - what must we learn?;Mateo;Nat Rev Clin Oncol,2013
4. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials;Chan;BMJ,2013
5. Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study;Tan;BMJ Open,2020
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient and public involvement and engagement in the development of innovative patient-centric early phase dose-finding trial designs;Research Involvement and Engagement;2024-06-19
2. Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance;BMJ;2023-10-20
3. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study;BMC Medicine;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3